TSRC, Tob. Sci. Res. Conf., 2015, 69, abstr. 110
Quantitative biomonitoring of urine mutagenicity: an alternative to classical ames test
(1) Celerion Inc., Lincoln, NE USA; (2) Somru BioScience Inc., Charlottetown, Canada
For more than 30 years the Ames test has been a widely used in-vitro method for the biomonitoring of urine mutagenicity due to exposure to tobacco products. Briefly, the Ames’ test detects point mutations and frame shifts based on the reversion of...